MedTrace Logo

Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome

NCT03342131 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2018-02-08

No results posted yet for this study

Summary

This study aims to find the change of serum wnt effectory moleculars and the association with Hs-CRP，cTnI and Prognosis in Patients with Acute Coronary Syndrome.

Conditions

  • Acute Coronary Syndrome

Interventions

OTHER

Circulating wnt 2 and wnt 4 concentration

Blood (150 each group) is obtained into ethylenediaminetetraacetic acid（EDTA） tubes from all subjects via antecubital venepuncture to explore circulating wnt 2 and wnt 4 concentration by ELISA. Continuous wnt2 and wnt4 concentration are measured in all patients with STEMI at 0 , 7days and 12 months after admission. Other patients with acute syndrome system are measured Wnt 2 and wnt4 only once within 24h after admission. Wnt2 and wnt4 concentration in Control group will be measured only once with 24h after admission.

Sponsors & Collaborators

  • Fudan University

    collaborator OTHER

  • The First Affiliated Hospital of Dalian Medical University

    lead OTHER

Principal Investigators

  • Rongchong Huang, Ph,D · The First Affiliated Hospital of Dalian Medical University

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-29
Primary Completion
2018-09-29
Completion
2019-03-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03342131 on ClinicalTrials.gov